Developed by MyoRX, the topical solution cream leverages the lipophilic properties of omega-3 fatty acids in combination with aspirin to create a medical delivery mechanism with minimal side effects.
ICAP Patent Brokerage CEO Dean Becker said the company is offering the topical cream to its global base of buyers.
"The portfolio provides an inexpensive and safe solution for individuals of all ages – from young athletes to elderly retirees – seeking an improved method for pain relief from a wide range of chronic pain ailments and issues," Becker added.
"Accordingly, this package is relevant to consumer pharmaceutical companies and healthcare firms wishing to formulate the next generation in topical multipurpose pain relievers for the public."